144 related articles for article (PubMed ID: 9198921)
1. [Natural surfactant in routine treatment of neonatal respiratory distress syndrome. Experiences from two central hospitals].
Grønn M; Silberg IE
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1453-6. PubMed ID: 9198921
[TBL] [Abstract][Full Text] [Related]
2. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
[TBL] [Abstract][Full Text] [Related]
3. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
[TBL] [Abstract][Full Text] [Related]
4. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
[TBL] [Abstract][Full Text] [Related]
5. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
[TBL] [Abstract][Full Text] [Related]
6. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial.
Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717
[TBL] [Abstract][Full Text] [Related]
7. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
[TBL] [Abstract][Full Text] [Related]
8. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D
Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
10. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
12. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH
Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245
[TBL] [Abstract][Full Text] [Related]
13. [Surfactant treatment of premature infants with respiratory distress syndrome].
Saugstad OD; Gloppestad K
Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
[TBL] [Abstract][Full Text] [Related]
14. [Early selective surfactant treatment--also to very premature infants treated with CPAP?].
Klamer A; Greisen G
Ugeskr Laeger; 2001 Dec; 163(50):7053-6. PubMed ID: 11794037
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of severe respiratory distress syndrome with surfactant].
Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
17. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
